Stars are more colorful than you think! Patience will reveal them; head outside tonight to see summer’s multi-hued stars.

Mars gets lost as it sinks deep into the sun’s afterglow. Meanwhile, Jupiter climbs above the predawn eastern horizon to join brilliant Venus.

In a report released yesterday, Pete Stavropoulos from Cantor Fitzgerald maintained a Buy rating on Axsome Therapeutics, with a price target of $153.00. The company’s shares closed yesterday at ...

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis continues the discussion on mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines and ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Arcturus Therapeutics (ARCT – Research Report) and Pharvaris (PHVS – Research ...

COLORADO SPRINGS, Colo. (KKTV) - The Colorado Springs Police Department (CSPD) is asking for help finding a missing 76-year-old man.

There’s a chance we could see a white dwarf star explosion this year. T Coronae Borealis, a binary star system and recurrent nova located roughly 3,000 light-years from Earth, is expected to erupt ...

5 analysts have expressed a variety of opinions on Arcturus Therapeutics ARCT over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below summarizes their ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company specializing in mRNA therapeutics and vaccines, stands at a critical juncture as it navigates a rapidly ...

Arcturus Therapeutics, founded in 2013 and headquartered in San Diego, has a history of developing mRNA-based medical solutions, including the world's first approved self-amplifying mRNA COVID ...

Q4 2024 Arcturus Therapeutics Holdings Inc Earnings CallThey involve known and unknown risks, uncertainties and assumptions that may cause actual results, performance and achievements to differ ...

SAN DIEGO, November 07, 2024--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious ...